Begin main content

Call for Patient Input: infliximab

August 4, 2017
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. infliximab Brand name Generic name Manufacture...

CDR Update 125

August 1, 2017
See CDR Update 125 for important news and information regarding the CADTH Common Drug Review.

Call for Patient Input: Orfadin

July 28, 2017
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. Orfadin Brand name Generic name Manufacturer I...

Call for Patient Input: guselkumab

July 27, 2017
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. guselkumab Brand name Generic name Manufacture...

New at CADTH — July 2017

July 13, 2017
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.